|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||36.76 / 45.79|
We'll sell our remaining shares in Panera and Costco to protect profits and move on.
Abbott Labs completed the acquisition of St. Jude Medical in January.
Insiders at these companies -- including Tailored Brands and Qualcomm -- have been scooping up shares of their own stock lately.
FDA EXPANDS EMERGENCY USE AUTHORIZATION FOR ABBOTT REALTIME ZIKA MOLECULAR TEST BEYOND PREVIOUS AUTHORIZATION TO IDENTIFY ZIKA USING SERUM, PLASMA AND URINE ONLY
FDA APPROVAL BROADENS PATIENT ACCESS TO THE COMPANY'S MRI-READY PACEMAKER, WHICH OFFERS OUTSTANDING LONGEVITY AND IMPROVES PHYSICIAN MONITORING
The president appears to be readying yet another executive order, to prevent skilled immigrants from working at U.S. companies or starting businesses here, but more H-1B visas may be needed.
Abbott Labs' shares fell nearly 1% in premarket trading after the company reported mixed earnings results.
Remember the old saying "the business of America, is business"? This is what we were all taught on the way up.
The weak companies could be clobbered.
ONE YEAR AFTER IMPLANT, 93 PERCENT OF PATIENTS WHO CONTINUED SCS THERAPY HAD LOWER AVERAGE DAILY MORPHINE-EQUIVALENT DOSES THAN PATIENTS WHO HAD THEIR SCS SYSTEM REMOVED
SYSTEM COMBINES SUPERIOR PAIN RELIEF WITH AN INTUITIVE APPLE™ TECHNOLOGY PROGRAMMING PLATFORM
ACCURATE STUDY CONFIRMS DRG STIMULATION PROVIDES SUPERIOR, TARGETED AND CONSISTENT PAIN RELIEF FOR PATIENTS WITH COMPLEX REGIONAL PAIN SYNDROME
ENHANCED SYSTEM ALLOWS BETTER THREE-DIMENSIONAL IMAGES OF ARRHYTHMIAS IN THE HEART
INNOVATIVE SOLUTION DESIGNED FOR BLOOD AND PLASMA SCREENING MAINTAINS HIGHEST LEVELS OF ACCURACY WHILE SUBSTANTIALLY INCREASING PRODUCTIVITY
NEXT GENERATION OF HARMONIZED SYSTEMS, COMBINED WITH RECENTLY LAUNCHED ALINIQ PROFESSIONAL SERVICES, PROVIDE A UNIQUE SOLUTION TO HELP LABS AND HOSPITAL SYSTEMS ACHIEVE MEASURABLY BETTER HEALTHCARE PERFORMANCE
The largest investor conference for the health care industry kicks off on Monday in San Francisco.
The lawyer is the husband of Trump adviser Kellyanne Conway and works in corporate litigation.
ABT could be on course for 10% earnings growth this year, but will investors reward the company with a higher share price?